CORDIS · 115854 · H2020
EBOVAC1 Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854
Coordinator: LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER (UK)
The overall aim of the EBOVAC programme is to assess the safety and efficacy of a novel prime boost prophylactic vaccine regimen against Ebola Virus Disease (EVD), which has been 100% effective in preclinical studies. This will be done via phase I, II and III trials carried out in the EU and in Africa, in response to the urgent public health need raised by the current Ebola epidemic. To expedite the development of the vaccine regimen, Phase II and Phase III trials will be carried out in parallel and therefore co-ordinated by two separate teams. Proposals responding to IMI2 Topic 1 will conseq…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
Co-funding: the European Union contributes €58.3M toward a total project budget of €98.0M — a funding rate of 60%, with the remainder covered by the consortium partners. The project runs over approximately 7 years from 2014-12-01 to 2021-11-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from UK
see all →- ENABLE — European Gram Negative Antibacterial Engine115583 · FP7 · €58.9M
- CRESCENDO — Collaborative & Robust Engineering using Simulation Capability Enabling Next Design Optimisation234344 · FP7 · €32.5M
- H2ME — Hydrogen Mobility Europe671438 · H2020 · €32.0M
- JIVE — Joint Initiative for hydrogen Vehicles across Europe735582 · H2020 · €32.0M
- LIGAND-AI — Protein-ligand data generation at scale to support computational hit finding and optimization101252959 · HORIZON · €29.9M
- ALICIA — All Condition Operations and Innovative Cockpit Infrastructure233682 · FP7 · €27.8M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €58.3M toward a total project budget of €98.0M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-JTI-IMI2-2014-02-single-stage.
- Who coordinates the project?
- The project is coordinated by LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER (UK).
- What is the project timeline?
- The project runs from 2014-12-01 to 2021-11-30 — approximately 7 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 115854.